Shanghai Pharmaceuticals buys major stake in special API maker
Shanghai Pharmaceuticals has bought a 70 per cent stake in ingredients developer and manufacturer Changzhou Kony Pharm in a bid to boost its standing in the API market.
News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs